A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

Scientists have developed a vaccine using virus-like particles (VLPs), which mimic the poliovirus but do not contain any genetic material. This removes the risk of infection while still triggering an ...

According to healthychildren.org, childhood vaccines consistently remain at very high and beneficial levels of safety and efficacy.

POLIO has emerged as a major challenge in Pakistan. It is not simply a challenge in the health sector, but has also become ...

Coverage with measles-mumps-rubella (MMR), diphtheria-tetanus-acellular pertussis (DTaP), polio, and varicella, or chickenpox vaccines, all declined in more than 30 states last year compared with ...

Funding cuts, including the U.S. withdrawal from WHO, threaten the global fight against polio. Over $133 million expected ...

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

US-based PharmaJet, a company dedicated to enhancing injectable performance through needle-free injection technology, has ...